Truffle Study - full name, author, year, journal
Trial of Umbilical and Fetal Flow in Europe: “2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial”
Author: Lees CC, et al.
Year: 2015
Journal: Lancet
TRUFFLE - clinical question:
In severe early-onset FGR between 26 and 32 weeks, what is the best monitoring strategy to time delivery so as to optimise 2-year neurodevelopmental outcome while minimising fetal/neonatal death
Why did the TRUFFLE trial matter?
TRUFFLE study design:
*All groups also had “safety-net” criteria mandating delivery regardless of randomisation, such as very abnormal FHR patters or severe Doppler deterioration
TRUFFLE - primary outcome
Primary outcome: survival without neurodevelopmental impairment at 2 years, defined using:
> Absence of cerebral palsy
> No severe neurosensory impairment
> No Bayley III score <85
TRUFFLE - main findings:
Among 503 randomised women:
> Median gestation at delivery was 30.7 weeks
> Mean birthweight was 1019g
Proportion surviving without neuroimpairment at 2 years was:
> 77% in the cCTG STV group
> 84% in the early DV group
> 85% in the late DV group
*The primary comparison across all 3 groups was not statistically significant (p = 0.09). However, among survivors, outcomes were best in the late DV group, and the investigators concluded that timing delivery using late DV changes together w cCTG might improve 2-yr developmental outcome
TRUFFLE - perinatal outcome
Overall outcomes were better than many expected for such severe early FGR:
- 92% survival
- Cerebral palsy only in about 1% of those with known outcome
-> reassured that with intensive surveillance and protocolised delivery, outcomes in severe early FGR can be better than historic series
What did TRUFFLE change in practice?
TRUFFLE one liner summary:
TRUFFLE showed that in severe early-onset FGR between 26 and 32 weeks, timing delivery using computerized CTG with ductus venosus Doppler—particularly waiting for later DV changes within a strict safety-net protocol—was associated with the best 2-year neurodevelopmental outcomes among survivors, and that delivery should not be based on cerebral Doppler changes alone.